Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China

Abstract Similar to global trends, the incidence rate of tuberculosis (TB) in China declined from 2000 to 2018. In this study, we aimed to evaluate TB trends in northern Guizhou Province and identify risk factors associated with rifampicin-resistant (RR) and concurrent extrapulmonary TB (EPTB). We a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ling Chen, Xuefeng Fu, Peng Tian, Qing Li, Dan Lei, Zhangli Peng, Quanxian Liu, Nana Li, Jianyong Zhang, Peng Xu, Hong Zhang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/68402c7aec9c4d7795d125fa70016065
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:68402c7aec9c4d7795d125fa70016065
record_format dspace
spelling oai:doaj.org-article:68402c7aec9c4d7795d125fa700160652021-12-02T19:12:35ZUpward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China10.1038/s41598-021-97595-82045-2322https://doaj.org/article/68402c7aec9c4d7795d125fa700160652021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97595-8https://doaj.org/toc/2045-2322Abstract Similar to global trends, the incidence rate of tuberculosis (TB) in China declined from 2000 to 2018. In this study, we aimed to evaluate TB trends in northern Guizhou Province and identify risk factors associated with rifampicin-resistant (RR) and concurrent extrapulmonary TB (EPTB). We analyzed data of TB patients hospitalized in Affiliated Hospital of Zunyi Medical University from 2011 to 2018, and assessed correlations between demographic characteristics of patients and RR-TB as well as concurrent EPTB. Our results showed that numbers of new, retreated, RR-TB and concurrent EPTB cases increased gradually from 2011 to 2018. Retreated patients had the highest odds of RR-TB but a lower likelihood of concurrent EPTB compared to new patients. Patients between 21 and 40 years of age had a higher likelihood of RR-TB compared to those 20 years and younger. Female patients and patients from Bijie city as well as the Miao ethnic minority had higher odds of concurrent EPTB. In summary, our data demonstrate upward trends in new, rifampicin-resistant and concurrent extrapulmonary TB cases in northern Guizhou Province of China, which should not be overlooked especially during and post the COVID-19 pandemic because TB is a greater long-term global health threat than COVID-19.Ling ChenXuefeng FuPeng TianQing LiDan LeiZhangli PengQuanxian LiuNana LiJianyong ZhangPeng XuHong ZhangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ling Chen
Xuefeng Fu
Peng Tian
Qing Li
Dan Lei
Zhangli Peng
Quanxian Liu
Nana Li
Jianyong Zhang
Peng Xu
Hong Zhang
Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
description Abstract Similar to global trends, the incidence rate of tuberculosis (TB) in China declined from 2000 to 2018. In this study, we aimed to evaluate TB trends in northern Guizhou Province and identify risk factors associated with rifampicin-resistant (RR) and concurrent extrapulmonary TB (EPTB). We analyzed data of TB patients hospitalized in Affiliated Hospital of Zunyi Medical University from 2011 to 2018, and assessed correlations between demographic characteristics of patients and RR-TB as well as concurrent EPTB. Our results showed that numbers of new, retreated, RR-TB and concurrent EPTB cases increased gradually from 2011 to 2018. Retreated patients had the highest odds of RR-TB but a lower likelihood of concurrent EPTB compared to new patients. Patients between 21 and 40 years of age had a higher likelihood of RR-TB compared to those 20 years and younger. Female patients and patients from Bijie city as well as the Miao ethnic minority had higher odds of concurrent EPTB. In summary, our data demonstrate upward trends in new, rifampicin-resistant and concurrent extrapulmonary TB cases in northern Guizhou Province of China, which should not be overlooked especially during and post the COVID-19 pandemic because TB is a greater long-term global health threat than COVID-19.
format article
author Ling Chen
Xuefeng Fu
Peng Tian
Qing Li
Dan Lei
Zhangli Peng
Quanxian Liu
Nana Li
Jianyong Zhang
Peng Xu
Hong Zhang
author_facet Ling Chen
Xuefeng Fu
Peng Tian
Qing Li
Dan Lei
Zhangli Peng
Quanxian Liu
Nana Li
Jianyong Zhang
Peng Xu
Hong Zhang
author_sort Ling Chen
title Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
title_short Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
title_full Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
title_fullStr Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
title_full_unstemmed Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China
title_sort upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern guizhou province of china
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/68402c7aec9c4d7795d125fa70016065
work_keys_str_mv AT lingchen upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT xuefengfu upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT pengtian upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT qingli upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT danlei upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT zhanglipeng upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT quanxianliu upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT nanali upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT jianyongzhang upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT pengxu upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
AT hongzhang upwardtrendsinnewrifampicinresistantandconcurrentextrapulmonarytuberculosiscasesinnorthernguizhouprovinceofchina
_version_ 1718377020451192832